Christopher Anderson, MD
Sports Medicine · Spokane Valley, WANPI 1205887056
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,603 of the $2,580 with a category attached, or 62.1%. 7 manufacturers reported payments, led by Arthrex at 43.4% of the total. Reporting peaked in 2023 at $2,035 and has fallen 91.5% since, to $172 in 2025.
Across 37 payments — averaging $69.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Summit Surgical Corp.$945
- Johnson & Johnson$250
- Sawtooth Surgical Solutions Inc$105
- Vericel Corporation$100
- Stryker$38
- plus $23 from 1 others
What the payments were for
- Travel & lodging$1,60362%
- Food & beverage$95637%
- Education$211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $1,120 |
| Summit Surgical Corp. | 7 | $945 |
| Johnson & Johnson | 5 | $250 |
| Sawtooth Surgical Solutions Inc | 2 | $105 |
| Vericel Corporation | 3 | $100 |
| Stryker | 1 | $38 |
| Boston Scientific | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TFN ADVANCED$125
How this compares
$2,580 in reported general payments places this provider in the 70th percentile of 132 sports medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 52 | $20,379 |
| Celecoxib | 17 | $789 |
| Cephalexin | 71 | $351 |
| Oxycodone Hcl | 32 | $248 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $92 |
| Ondansetron Hcl | 21 | $69 |
| Clindamycin Hcl | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $250 | $20,37952 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 132 sports medicine providers in Washington.
Other sports medicine in Spokane Valley
- Geoffrey HiggsProsser$569K
- Nicholas KennedyYakima$112K
- Nicholas VaudreuilEverett$49K
- Adam PourchoSeattle$38K
- Christopher WahlIssaquah$37K
- Nicholas WilcoxMarysville$36K
- Mathew TaylorPullman$36K
- Brandon NudelmanBellevue$32K
- Judd FitzgeraldKennewick$14K
- Taylor BuuckSeattle$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.